Staphylococcus aureus Co-Infection in COVID-19 Patients: Virulence Genes and Their Influence on Respiratory Epithelial Cells in Light of Risk of Severe Secondary Infection
- PMID: 39337536
- PMCID: PMC11431965
- DOI: 10.3390/ijms251810050
Staphylococcus aureus Co-Infection in COVID-19 Patients: Virulence Genes and Their Influence on Respiratory Epithelial Cells in Light of Risk of Severe Secondary Infection
Abstract
Pandemics from viral respiratory tract infections in the 20th and early 21st centuries were associated with high mortality, which was not always caused by a primary viral infection. It has been observed that severe course of infection, complications and mortality were often the result of co-infection with other pathogens, especially Staphylococcus aureus. During the COVID-19 pandemic, it was also noticed that patients infected with S. aureus had a significantly higher mortality rate (61.7%) compared to patients infected with SARS-CoV-2 alone. Our previous studies have shown that S. aureus strains isolated from patients with COVID-19 had a different protein profile than the strains in non-COVID-19 patients. Therefore, this study aims to analyze S. aureus strains isolated from COVID-19 patients in terms of their pathogenicity by analyzing their virulence genes, adhesion, cytotoxicity and penetration to the human pulmonary epithelial cell line A549. We have observed that half of the tested S. aureus strains isolated from patients with COVID-19 had a necrotizing effect on the A549 cells. The strains also showed greater variability in terms of their adhesion to the human cells than their non-COVID-19 counterparts.
Keywords: COVID-19; SARS-CoV-2; Staphylococcus aureus; adhesion.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
SARS-CoV-2 infection predisposes patients to coinfection with Staphylococcus aureus.mBio. 2024 Aug 14;15(8):e0166724. doi: 10.1128/mbio.01667-24. Epub 2024 Jul 22. mBio. 2024. PMID: 39037272 Free PMC article.
-
The impact of the COVID-19 pandemic on Staphylococcus aureus infections in pediatric patients admitted with community acquired pneumonia.Sci Rep. 2024 Jul 8;14(1):15737. doi: 10.1038/s41598-024-66071-4. Sci Rep. 2024. PMID: 38977804 Free PMC article.
-
Genetic diversity and virulence characteristics of Staphylococcus aureus isolates from cases of bovine mastitis.Microb Pathog. 2020 Jul;144:104171. doi: 10.1016/j.micpath.2020.104171. Epub 2020 Mar 26. Microb Pathog. 2020. PMID: 32224210
-
Clinical outcomes in patients co-infected with COVID-19 and Staphylococcus aureus: a scoping review.BMC Infect Dis. 2021 Sep 21;21(1):985. doi: 10.1186/s12879-021-06616-4. BMC Infect Dis. 2021. PMID: 34548027 Free PMC article.
-
Bacterial co-infections with SARS-CoV-2.IUBMB Life. 2020 Oct;72(10):2097-2111. doi: 10.1002/iub.2356. Epub 2020 Aug 8. IUBMB Life. 2020. PMID: 32770825 Free PMC article. Review.
Cited by
-
Efficacy of Three Kayviruses Against Staphylococcus aureus Strains Isolated from COVID-19 Patients.Antibiotics (Basel). 2025 Mar 3;14(3):257. doi: 10.3390/antibiotics14030257. Antibiotics (Basel). 2025. PMID: 40149068 Free PMC article.
-
Nasopharyngeal Staphylococcus aureus Isolation and Bacterial Culture Profiles in COVID-19 Patients: A Comparative Study Based on Lung Involvement.Cureus. 2025 Jul 2;17(7):e87149. doi: 10.7759/cureus.87149. eCollection 2025 Jul. Cureus. 2025. PMID: 40755608 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous